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Abstract
Cardiovascular diseases are the one of main causes of lethality in all developed countries. In the structure of this group of 
diseases ischemic heart disease (IHD) occupies the leading place. In the last decade methods of myocardium surgical revasculariza-
tion that allow to remodel the myocardium essentially and to increase its functional features significantly are developed. Alongside 
with it, myocardium surgical revascularization doesn’t eliminate main causes of atherosclerotic diseases. Ineffective rehabilitation, 
including insufficient management of main factors of the cardiovascular risk may essentially decrease results of this operation. 
The aim of the study was to elaborate the integral evaluation of the effectiveness of the renewal treatment of patients with 
IHD after myocardium surgical revascularization. For this aim we offer to use metabolic (leptin, НОМА index, atherogenicity 
index) and clinical-functional indices (body mass index, physical working ability and ejection fraction (EF) of the left ventricle, 
anxiety and depression level) before and after the renewal treatment and the result – integral index (I), calculated by the formula: 
 (1 , 2, .. n) (1 , 2, .. n)M FI
N
+ + + ++
= , where М
(1+2+n)
 – metabolic (leptin, НОМА index, atherogenicity index) indices, F
(1+2+n) 
– functional and 
anthropometric ones (BMI, physical working ability, and EF of the left ventricle). 
The use of the integral index before the renewal treatment allows to elaborate the effective rehabilitation program, and after – 
to study the effectiveness of elaborated complexes and to decrease risks of IHD progression. 
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1. Introduction
Among methods of surgical treatment of ischemic heart disease (IHD) the most often used 
are aortocoronary (ACB) and mammary bypass (MCB), intra-skin interventions on coronary ves-
sels [1]. The aim of any of aforesaid cardiovascular interventions is a renewal of the coronary blood 
circulation, elimination of mean clinical manifestations of IHD, increase of operated patients’ life 
quality and duration, increase of their physical working ability [2]. According to the data of many 
authors, myocardium surgical revascularization (MSR) in 75–85 % of cases takes off from the pain 
syndrome, increases the life quality and 5-year prognosis of survivability. Alongside with it, MSR 
doesn’t eliminate main causes of atherosclerotic diseases. Ineffective rehabilitation, including in-
sufficient management of main factors of the cardiovascular risk may essentially decrease results 
of this operation [3, 4].
Despite the fact that operations on myocardium revascularization are directed on the work-
ing ability renewal and human life quality increase, these cardiovascular interventions themselves 
are the essential stress and dysadaptation factors for a patient [5]. The absence of the united strategy 
and tactics of the renewal treatment after myocardium surgical revascularization, and also underes-
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timation of hypodynamia and hypokinesia factors in the pathogenesis of postsurgical complications 
leads to IHD progression [6, 7]. The analysis of literary data and own experience testify to the fact 
that the system approach, including the use of the integral evaluation of the risk of complications 
progression after myocardium surgical revascularization, especially at the concomitant pathology, 
wasn’t properly developed and used in the stage renewal treatment [8].
There are well-known different methods of forecasting the development of cardiovascular 
complications after myocardium revascularization by the determination of cholesterol level, de-
tection of features of stenosis and localization of the atherosclerotic plaque in coronary arteries; 
stenosis type, myocardium ischemia degree by data of Holter monitoring of an electrocardiogram; 
analysis of the speed of nitrogen-containing preparation metabolism; study of polymorphism gen-
otypes and other [9, 10]. But these methods don’t have the complex approach to the integral eval-
uation of patients with IHD after myocardium surgical revascularization and are difficult in use at 
the renewal treatment stage. 
2. Aim of research
To elaborate the integral evaluation of the effectiveness of the renewal treatment of patients 
after myocardium surgical revascularization. 
3. Materials and methods of research
65 patients, 58,7±8,9 years old after aortocoronary bypass (ACB), who received the standard 
medicamental therapy, namely nitrates, beta-blockers, calcium antagonists, ATE inhibitors, dis-
agregants, diuretics, hypolipidemic drugs and the complex of sanatorium rehabilitation were under 
observation at the treating-recovery complex “Bila acacia” (Odessa city, Ukraine). Patients of the 
first group (17 persons) were admitted for rehabilitation in 7 days after the surgical treatment at the 
absence of postsurgical complications at severe concomitant diseases. The contraindications for 
early admission at the specialized rehabilitation department were: often and long attacks of angina 
of rest and effort, unstable angina; recent myocardium infarction; insufficiency of blood circulation 
of IV f.c. by NYHA; expressed rhythm disorders; expressed arterial hypertension with an injury 
of inside organs, that is badly subjected to correction; postsurgical complications; concomitant dis-
eases, accompanied by fever; residual phenomena of thromboembolia in cerebral vessels. Patients 
of the second group (48 persons) were admitted for rehabilitation in 1–2 months after the operation. 
The research algorithm (before and after treatment) included the collection of anamnesis, dynamic 
clinical observation of objective and subjective state of patients, laboratory diagnostics by the stan-
dard methods [11] (biochemical blood analysis (aspartat-aminotransferase alanine-aminotrans-
ferase, creatinine, phosphokinase, troponin, C-reactive protein, lipidogram, blood sugar, insulin, 
НОМА index, leptin and instrumental research methods (ECG, heart US, Holter monitoring of 
ECG, measuring of arterial pressure, heart contractions frequency, six-minute test (SMT)). For 
evaluating the psychological state, HADS and Spielberg anxiety scales were used, life quality was 
evaluated by SF-36 scale. 
For the integral evaluation before and after the renewal treatment metabolic and clinical 
functional indices before and after treatment, namely, metabolic (leptin, НОМА index, atheroge-
nicity index) and clinical-functional (body mass index, (BMI) physical working ability and ejection 
fraction (EF) of the left ventricle, anxiety and depression level) and the result – integral index (I) 
was calculated by the formula: 
(1 , 2 ..n) (1 2, ..n)M FI ,
N
+ + + ++
=
where М
(1+2+n)
 – metabolic indices (leptin, НОМА index, atherogenicity index); F
(1+2+n) 
– functional 
and anthropometric indices (BMI, physical working ability and ejection fraction (EF) of the left 
ventricle); N – number of calculated indices.
At that the quantitative evaluation of indices from 1 to 3 points was taken into account 
(Table 1). 
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Table 1
Criteria of point evaluation of clinical indices 
Indices
Criteria
Low 
(1 point)
Critical 
(2 points)
High 
(3 points)
1. Metabolic
1.1. Leptin level, mcg/l ≤18,55 18,55–20,69 ≥20,69 
1.2. Atherogenicity level ≤4,36 4,36–5,21 ≥5,21 
1.3. HOMA index ≤4,6 4,6–10,9 ≥10,9
2. Clinical-functional 
2.1. BMI kg/m2 ≤23,1 23,1–34,4 ≥34,4
2.2. Physical working ability (SMT) ≥310 310–265 ≤265
2.3. EF, % ≥68,1 55,3–68,1 ≤55,3
2.4. Anxiety (by HADS), points 0–7 8–10 ≥11 
2.5. Depression (by HADS), points 0–7 8–10 ≥11
The renewal treatment (RT) course included: the saving-training regime of moving activity, 
climate-, diet-, physiotherapy (magnitolazerotherapy), balneotherapy (“dry” carbonic bathes) and 
TFC. The treatment course was 21 days.
5. Results
At admission to RT the absence of complaints, connected with the complete regression of 
IHD symptoms after surgical MR was observed in 15,8 % of patients, but 35,4 % of patients com-
plained for discomfort in the precordial zone, 64,3 % of patients suffered from general weakness 
and fast tiredness, 10,7 % observed short-term pressing pains behind the breastbone at physical 
loads, inessential short breath was observed in 25,9 % of patients, 17,1 % complained for tachycar-
dia, 20,3 % – for “breaks” in the heart work. 
In 55,2 % of patients was observed an excessive weight before RT, BMI in patients of the 
second group was by 7,0 % higher (Table 2). Before RT in both groups of patients were revealed 
metabolic changes – the increase of atherogenicity index in the first group by 11,3 % more), НОМА 
and leptin (in the second group by 21,6 % and by 11,2 % more comparing with the first one). In 
patients of the second group was observed the rise of anxiety and depression levels by HADS by 
33,9 % and 22,5 % comparing with patients of the first group. We didn’t observe any reliable dif-
ferences at the determination of tolerance to physical loads and EF in patients of both groups. After 
RT we observed the reliable improvement of metabolic and clinical-functional indices (Table 2), 
namely the decrease of atherogenicity indices by 25,5 and 18,0 % in the first and second groups, 
НОМА – 13,2 and 8,0 %, leptin level – 28,7 and 19,3 % respectively (р≤0,05).
At the evaluation of the neuropsychic state after RT we observed the decrease of the anxi-
ety level (by 29,1 and 25,2 %) and depression level (by 25,4 and 21,7 %) in patients of the first and 
second groups, respectively. At the analysis of the dynamics of tolerance to physical loads – the 
increase of distance, passed by patients in six minutes – in the first and second groups by 18,1 and 
10,7 % respectively. The positive dynamics was also at EchoCS examination – EF increase in pa-
tients of both groups – by 9,2 and 8,2 % respectively.
At the determination of the integral index at admission to RT in patients of the second group, 
I was by 12,5 % higher, than in patients of the first one. After RT – the decrease of this index in the 
first group by 37,5 %, and in the second one – by 29,3 %.
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Table 2
Clinical-laboratory characteristics of examined patients that were at the sanatorium treatment 
Indices
Groups
А1 А2
Before RT After RT Before RT After RT
BMI kg/m2 34,4±2,6 30,9±2,2 36,8±2,7 34±2,7
Atherogenicity index 7.33+0,15 5,46±0,09** 6.51±1,18 5,34±0,16*
НОМА index 13,55±1,25 11,76±1,34** 16,47±1,18 15,16±1,57
Leptin, mcg/l 21,62±1,07 15,4±1,27** 25,55±3,41 19,3±2,45*
Anxiety scale HADS (points) 6,12±0,95 4,34±1,57** 8,20±1,73 6,13±1,11*
Depression scale HADS 
(points) 7,51±1,24 5,6±1,1** 9,2±1,2 7,2±1,4*
SMT (M) 262,6±30,47 310,2±25,91** 285,1±14,33 315,5±17,47*
EF (%) 54,15±2,73 59,14±2,12* 54,37±2,81 58,85±2,44*
Integral index (I) 2,0±0,75 1,25±0,37** 2,25±0,56 1,59±0,50*
Note: The difference of indices is reliable comparing with: * – before and after treatment (р<0,05); ** – between groups after treat-
ment (р< 0,05)
6. Discussion of results
Literary data prove the effectiveness of physical rehabilitation of patients after cardiosurgi-
cal interventions, who are at 2 or 3 rehabilitation level and have practically no complications risk 
after ACB [12]. But rehabilitation protocols of cardiorehabilitation, used at the early stage, are sub-
jective. More often the physical rehabilitation after ACB includes respiratory exercises, because it 
is used to think, that physical exercises must be avoided during at least 3 months after surgery [13]. 
From the other side, if one avoids physical activity in first weeks after surgery, it results in the more 
expressed atrophy of breast muscles and shoulder girdle [14]. That is just why, we find it necessary 
to realize the early RT, and the use of the integral evaluation helps to elaborate RT complexes and 
to determine its effectiveness. Thus, according to our data, in patients, admitted to hospital after 
myocardium surgical revascularization was observed the essential increase of health state, because 
the surgical intervention eliminates the anatomic base of pathology and leads to hemodynamics 
and life quality increase that is noted in works by many authors [15, 16].
Among risk factors of IHD development in examined persons prevailed insufficient phys-
ical activity that resulted in BMI increase, especially in the group of patients, who didn’t receive 
the early RT. As it is known, obesity is considered by many researchers as a predictor of angina 
return development and late myocardium infarction after aortocoronary bypass [17]. At the same 
time insulin resistance or hyperinsulinemia that are just risk factors of cardiovascular diseases, 
favoring dyslipidemia development, strengthening rheological properties, hemostasis and water 
balance disorder, often develop in patients at the background of obesity [18], that is distinctly traced 
also in our studies – the increase of НОМА index and leptin level in patients of the second group 
is more than in ones of the first group. The lower atherogenicity indices in patients of the second 
group comparing with ones of the first group before RV are connected, from our point of view, with 
the regular intake of hypolipidemic drugs (recommended at the stationary stage), but after RT the 
reliable decrease of this index was observed in patients of the first group after all. 
Data of the Institute of sport medicine, prophylaxis and rehabilitation testify to the fact that 
the early (1–2 weak after surgery) start of the adapted program of cardiorehabilitation is safe, ac-
celerates recovery, doesn’t increase problems with the sternum and favors psychological recovery 
[19]. It is used to think that depression can be both a factor of myocardium infarction development 
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and a cause of the complicated clinical course after cardiosurgical operations [20]. In our study at 
the evaluation of the neuropsychic state in patients of the second group the indices of anxiety and 
depression before RT were reliably higher, and after TR – their reliable decrease was observed in 
patients of the first group that also testifies to the necessity of the early renewal treatment. 
In was proved, that the renewal of the myocardium contraction ability after ACB is realized 
gradually that is connected also with the state of myocardium devitalization [21], so EchoCG with 
EF determination was carried out in 3–6 months after the surgical intervention. That is just why 
patients before RT had no essential differences of EF between groups, and after the treatment we 
observed the positive dynamics, especially in the first group. 
At the complex evaluation of patients before RT the integral index (I) in the first group was 
by 12, % lower, comparing with the second one that proves all aforesaid about the fact that patients, 
who don’t receive the correspondent early renewal treatment have a higher risk of IHD progression, 
considered by us as IHD critical progression. After the renewal treatment in patients of both groups 
was observed the low level of IHD progression, better result, namely the reliable decrease (р≤0,05) 
of I by 8,2 % comparing with patients from the second group. 
The shortcoming of our research is an insufficient term of observation of patients after the 
renewal treatment, at the same time it is necessary to carry out the correlative analysis of factors 
that influence IHD progression. 
7. Conclusions
1. The early stage of RT in patients with IHD after myocardium surgical revascularization 
is a necessary part of medical rehabilitation of this category of patients that allows to realize the 
timely correction of metabolic, neuropsychic and functional deviations and optimization of the 
renewal treatment. 
2. The integral evaluation before the beginning of RT allows to elaborate the effective re-
newal treatment of these patients. 
3. The evaluation of the effectiveness of the renewal treatment of patients with IHD after 
myocardium surgical revascularization is an important problem of medical rehabilitation. 
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